References
- Selvin E, Erlinger TP. Prevelance of and risk factors for peripheral arterial disease in the United States. Results From the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004; 110: 738–43
- The Sage Group. The Sage Group Report. New Jersey: Branchburg, 2005.
- Pignon B, Sevestre MA, Chatelain D, Albertini JN, Sevestre H. Histological changes after implantation of autologous bone marrow mononuclear cells for chronic critical limb ischemia. Bone Marrow Transplant. 2007; 39: 647–8
- Albers M, Fratezi AC, De Luccia N. Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease. J Vasc Surg. 1992; 16: 54–9
- Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells. 2004; 22: 649–58
- Zhang Y, Li C, Jiang X, Zhang S, Wu Y, Liu B, Tang P, Mao N. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34 + cells. Exp Hematol. 2004; 32: 657–64
- Takako, G, Naoto, F, Akira, Kazuo, K, Koji, K, Hiroyuki, T, , et al. Search for appropriate experimental methods to create stable hind-limb ischemia in mouse. Exp Clin Med 2006;31:128–32.
- Boxberger S, Jørgensen B, Feldmann S, Ehninger G, Bornhäuser M, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004; 22: 377–84
- Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T, Kaneda Y. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb. 2006; 13: 77–81
- Esato K, Hamano K, Li TS, Furutani A, Seyama A, Takenaka H, et al. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant. 2002; 11: 747–52
- Taguchi A, Ohtani M, Soma T, Watanabe M, Kinosita N. Therapeutic angiogenesis by autologous bone-marrow transplantation in a general hospital setting. Eur J Vasc Endovasc Surg. 2003; 25: 276–8
- Kim S, Han H, Chae G, Lee S, Sun H, Yoon J, et al. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells. 2006; 24: 1620–6
- Kajiguchi M, Kondo T, Izawa H, Kobayashi M, Yamamoto K, Shintani S, et al. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J. 2007; 71: 196–201
- Fadini GP, Avogaro A. Autologous transplantation of granulocyte colony stimulating factor- mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diab Care. 2006; 29: 478–9
- Kern S, Eichler H, Stoene J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24: 1294–301